Frequency of severe infections and correlation with immune markers in patients with neuromyelitis optica spectrum disorders treated with rituximab: a Swedish cohort study

被引：0
|
作者：
Carlsson, Olof [1 ,2 ]
Jonsson, Dagur Ingi [1 ,3 ]
Brundin, Lou [1 ,2 ]
Iacobaeus, Ellen [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Neurophysiol, Stockholm, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P722/1414
引用
收藏
页码：622 / 623
页数：2
相关论文
共 50 条
  • [21] Therapeutic Target of Memory B Cells Depletion Helps to Tailor Administration Frequency of Rituximab in Neuromyelitis Optica Spectrum Disorders Patients
    Frenay, Christine Lebrun
    Cohen, Mikael
    Romero, Gwendoline
    Rosenthal-Allieri, Alessandra
    Ticchioni, Michel
    [J]. NEUROLOGY, 2016, 86
  • [22] Application of the 2015 neuromyelitis optica spectrum disorders diagnostic criteria in a cohort of Chinese patients
    He, Mianwang
    Wu, Lei
    Huang, Dehui
    Yu, Shengyuan
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [23] Monitoring CD27+memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study
    Cohen, M.
    Romero, G.
    Bas, J.
    Ticchioni, M.
    Rosenthal, M.
    Lacroix, R.
    Brunet, C.
    Rico, A.
    Pelletier, J.
    Audoin, B.
    Lebrun, C.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 373 : 335 - 338
  • [24] Monitoring CD27+memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: results from a bicentric study
    Cohen, Mikael
    Romero, Gwendoline
    Bas, Joachim
    Ticchioni, Michel
    Rosenthal, Maria
    Lacroix, Romaric
    Brunet, Corinne
    Lamy, Audrey Rico
    Pelletier, Jean
    Audoin, Bertrand
    Frenay, Christine Lebrun
    [J]. NEUROLOGY, 2017, 88
  • [25] Efficacy and safety of rituximab in patients with refractory neuromyelitis optica spectrum disorders: A prospective observation in Iranian cases
    Ahadi, Maral Seyed
    Moghadasi, Abdorreza Naser
    Asgari, Nasrin
    Sahraian, Mohammad Ali
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2020, 11 (02) : 155 - 162
  • [26] Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab
    Kim, W.
    Kim, S. -H.
    Huh, S. -Y.
    Kong, S. -Y.
    Choi, Y. J.
    Cheong, H. J.
    Kim, H. J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (06) : 975 - 980
  • [27] Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder
    Su-Hyun Kim
    Jae-Won Hyun
    In Hye Jeong
    AeRan Joung
    Joung-Lim Yeon
    Thomas Dehmel
    Ortwin Adams
    Bernd C. Kieseier
    Ho Jin Kim
    [J]. Journal of Neurology, 2015, 262 : 696 - 700
  • [28] real-world safety data of rituximab among mexican patients with neuromyelitis optica spectrum disorders
    Thomas, Domingo Coutinho
    Lopez, Yazmin Martinez
    Villanueva, Homero Alcocer
    Lopez, Sarai Rivera
    Gonzalez, Jose Gonzalez
    Vazquez, Teresita Corona
    Rivas, Veronica
    Rivera, Jose De Jesus Flores
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1127 - 1127
  • [29] Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder
    Kim, Su-Hyun
    Hyun, Jae-Won
    Jeong, In Hye
    Joung, AeRan
    Yeon, Joung-Lim
    Dehmel, Thomas
    Adams, Ortwin
    Kieseier, Bernd C.
    Kim, Ho Jin
    [J]. JOURNAL OF NEUROLOGY, 2015, 262 (03) : 696 - 700
  • [30] Suppression of humoral responses after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab
    Kim, W.
    Kim, S. H.
    Huh, S. Y.
    Cho, J. Y.
    Kong, S. Y.
    Choi, Y. J.
    Kim, W. J.
    Kim, H. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 458 - 458
12345